CASI Pharmaceuticals Inc (CASI) – Strategy, SWOT and Corporate Finance Report

CASI Pharmaceuticals Inc (CASI) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for treating cancer and other unmet medical needs. The company’s product EVOMELA (melphalan for injection) an intravenous formulation for the treatment of multiple myeloma. Its pipeline product portfolio includes CID-103 for treatment of multiple myeloma; CNTC 19 for hematological malignancies; ZEVALIN for treatment of relapsed/refractory, low-grade B-cell non-Hodgkin’s lymphoma (NHL); MARQIBO for treatment of Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL); BI-1206 for non-hodgkin's lymphoma and solid tumors; CB-5339 AML/MDS and solid tumors; Octreotide LAI for treatment of acromegaly and symptoms associated with neuroendocrine tumors. The company operates subsidiaries in the US and China and a research and development center in Beijing, China. CASI is headquartered in Rockville, Maryland, the US.

Scope

• Detailed information on CASI Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting CASI Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of CASI Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about CASI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of CASI Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess CASI Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on CASI Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Zivo Bioscience Inc

Viva Biotech Holdings

Shanghai GeneChem Co Ltd

Natsar Pharmaceuticals Inc

Hualan Biological Engineering Inc

Genentech USA Inc

Fennec Pharmaceuticals Inc

Cardiff Oncology Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

CASI Pharmaceuticals Inc - Key Facts

CASI Pharmaceuticals Inc - Key Employees

CASI Pharmaceuticals Inc - Key Employee Biographies

CASI Pharmaceuticals Inc - Major Products and Services

CASI Pharmaceuticals Inc - History

CASI Pharmaceuticals Inc - Company Statement

CASI Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

CASI Pharmaceuticals Inc - Business Description

R&D Overview

CASI Pharmaceuticals Inc - Corporate Strategy

CASI Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

CASI Pharmaceuticals Inc - Strengths

CASI Pharmaceuticals Inc - Weaknesses

CASI Pharmaceuticals Inc - Opportunities

CASI Pharmaceuticals Inc - Threats

CASI Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

CASI Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 13, 2021: CASI Pharmaceuticals Announces First Quarter 2021 Financial Results

May 11, 2021: CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021

Mar 30, 2021: CASI Pharmaceuticals Announces Full Year 2020 Financial Results

Feb 16, 2021: CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates

Dec 16, 2020: CASI Pharmaceuticals announces appointment Of Chief Financial Officer

Nov 09, 2020: CASI Pharmaceuticals announces third quarter 2020 financial results

Aug 10, 2020: CASI Pharmaceuticals announces second quarter 2020 financial results

Apr 27, 2020: CASI Pharmaceuticals receives loan under Paycheck Protection Program

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

CASI Pharmaceuticals Inc, Key Facts

CASI Pharmaceuticals Inc, Key Employees

CASI Pharmaceuticals Inc, Key Employee Biographies

CASI Pharmaceuticals Inc, Major Products and Services

CASI Pharmaceuticals Inc, History

CASI Pharmaceuticals Inc, Other Locations

CASI Pharmaceuticals Inc, Subsidiaries

CASI Pharmaceuticals Inc, Key Competitors

CASI Pharmaceuticals Inc, Ratios based on current share price

CASI Pharmaceuticals Inc, Annual Ratios

CASI Pharmaceuticals Inc, Annual Ratios (Cont…1)

CASI Pharmaceuticals Inc, Interim Ratios

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

CASI Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

CASI Pharmaceuticals Inc, Performance Chart (2016 – 2020)

CASI Pharmaceuticals Inc, Ratio Charts

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports